The NQO1 allelic frequency in hindu population of central India varies from that of other Asian populations

Indian Journal of Human Genetics

Volumn 16, Issue 3, 2010, Pages 133-137

  Parihar, Sher S ^a   Chauhan, U K ^a  

^a Awdhesh Pratap Singh University   (India)

Author keywords

Cancer; NQO1; polymorphism

Indexed keywords

REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE (PHOSPHATE) DEHYDROGENASE (QUINONE); REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE (PHOSPHATE) DEHYDROGENASE (QUINONE) 1; UNCLASSIFIED DRUG;

ALLELE; ARTICLE; ASIAN; DNA POLYMORPHISM; FEMALE; GENE FREQUENCY; GENE MUTATION; GENETIC ASSOCIATION; HUMAN; HUMAN CELL; INDIA; MALE; NORMAL HUMAN; POPULATION GENETICS; WILD TYPE;

EID: 78650097696     PISSN: 09716866     EISSN: 1998362X     Source Type: Journal    
DOI: 10.4103/0971-6866.73403     Document Type: Article

References (29)

1. Lind C, Cadenas E, Hochstein P, Ernster L. DT-diaphorase: Purification, properties, and function. Methods Enzymol 1990;186:287-301.
2. Kim K, Suk H. Reduction of nitrosoarene by purified NAD (P) H-quinone oxidoreductase. J Biochem Mol Biol 1999;32:321-5.
3. Dinkova-Kostova AT, Talalay P. Persuasive evidence that quinone reductase type 1 (DT-diaphorase) protects cells against the toxicity of electrophiles and reactive forms of oxygen. Free Radic Biol Med 2000;29:231-40.
4. Jaiswal AK. Human NAD (P) H: Quinone oxidoreductase (NQO1) gene structure and induction by dioxin. Biochemistry 1991;30:10647-53.
5. Jaiswal AK. Regulation of genes encoding NAD (P) H: Quinone oxidoreductase. Free Radic Biol Med 2000;29:254-62.
6. Wiencke JK, Spitz MR, McMillan A, Kelsey KT. Lung cancer in Mexican-Americans and African-Americans is associated with the wild-type genotype of the NAD (P) H: Quinone oxidoreductase polymorphism. Cancer Epidemiol Biomarkers Prev 1997;6:87-92.
7. Traver RD, Siegel D, Beall HD, Phillips RM, Gibson NW, Franklin WA, et al. Characterization of a polymorphism in NADP (H): Quinone oxidoreductase (DT diaphorase). Br J Cancer 1997;75:69-75.
8. Kelsey KT, Ross D, Traver RD, Christiani DC, Zuo ZF, Spitz MR, et al. Ethnic variation in the prevalence of a common NAD (P) H: Quinone oxidoreductase polymorphism and its implications for anti-cancer chemotherapy. Br J Cancer 1997;76:852-4.
9. Ross D, Traver RD, Siegel D, Kuehl BL, Misra V, Rauth AM. A polymorphism in NAD (P) H: Quinone oxidoreductase (NQO1): Relationship of a homozygous mutation at position 609 of the NQO1 cDNA to NQO1 activity. Br J Cancer 1996;74:995-6.
10. Traver RD, Rothman N, Smith MT, Yin SY, Hayes RB, Li GL, et al. Incidence of a polymorphism in NAD (P) H: Quinone oxidoreductase (NQO1). Proc Am Assoc Cancer Res 1996;37:278.
11. Asher G, Lotem J, Kama R, Sachs L, Shaul Y. NQO1 stabilizes p53 through a distinct pathway. Proc Natl Acad Sci USA 2002;99:3099-104.
12. Smith MT. Benzene, NQO1, and genetic susceptibility to cancer. Proc Natl Acad Sci USA 1999;96:7624-6.
13. Kiyohara C, Yoshimasu K, Takayama K, Nakanishi Y. NQO1, MPO, and the risk of lung cancer: A Huge review. Genet Med 2005;7:463-78.
14. Begleiter A, Hewitt D, Maksymiuk AW, Ross DA, Bird RP. A NAD (P) H: Quinone Oxidoreductase 1 Polymorphism Is a Risk Factor for Human Colon Cancer. Cancer Epidemiol Biomarkers Prev 2006;15:2422-6.
15. Fowke JH, Shu XO, Dai Q, Jin F, Cai Q, Gao YT, et al. Oral Contraceptive Use and Breast Cancer Risk: Modification by NAD (P) H: Quinone Oxoreductase (NQO1) Genetic Polymorphisms. Cancer Epidemiol Biomarkers Prev 2004;13:1308-15.
16. Cho CG, Lee SK, Nam SY, Lee MS, Lee SW, Choi EK, et al. Association of the GSTP1 and NQO1 Polymorphisms and Head and Neck Squamous Cell Carcinoma Risk. J Korean Med Sci 2006;21:1075-9.
17. Chen H, Lum A, Seifried A, Wilkens LR, Le Marchand L. Association of the NAD (P) H: Quinone Oxidoreductase 609C3T Polymorphism with a Decreased Lung Cancer Risk. Cancer Res 1999;59:3045-8.
18. Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 1988;16:1215.
19. Zhang J, Schulz WA, Li Y, Wang R, Zotz R, Wen D, et al. Association of NAD (P) H: Quinone oxidoreductase 1 (NQO1) C609T polymorphism with esophageal squamous cell carcinoma in a German Caucasian and a northern Chinese population. Carcinogenesis 2003;24:905-9.
20. Saravana DS, Vinayagamoorthy N, Agrawal M, Biswas A, Biswas R, Naoghare P, et al. Distribution of detoxifying genes polymorphism in Maharastrian Population of CentralIndia. Chemosphere 2008;70:1835-9.
21. Chikako K, Kouichi Y, Koichi T, Yoichi N. NQO1, MPO, and the risk of lung cancer: A HuGE review. Genet Med 2005;7:463-78.
22. Toncheva DI, Von Ahsen N, Atanasova SY, Dimitrov TG, Armstrong VW, Oellerich M. Identification of NQO1 and GSTs genotype frequencies in Bulgarian patients with Balkan endemic nephropathy. J Nephrol 2004;17:384-9.
23. Zhang J, Schulz WA, Li Y, Wang R, Zotz R, Wen D, et al.Association of NAD (P) H: Quinone oxidoreductase 1 (NQO1) C609T polymorphism with esophageal squamous cell carcinoma in a German Caucasian and a northern Chinese population. Carcinogenesis 2003;24:905-9.
24. Cho CG, Lee SK, Nam SY, Lee MS, Lee SW, Choi EK, et al. Association of the GSTP1 and NQO1 Polymorphisms and Head and Neck Squamous Cell Carcinoma Risk. J Korean Med Sci 2006;21:1075-9.
25. Alexandrie AK, Nyberg F, Warholm M, Rannug A. Influence of CYP1A1, GSTM1, GSTT1, and NQO1 Genotypes and Cumulative Smoking Dose on Lung Cancer Risk in a Swedish Population. Cancer Epidemiol Biomarkers Prev 2004;13:908-14.
26. Biramijamal F, Sanati MH, Banoei MM, Bayat B, Arjmand S, Farhud D. Genetic polymorphism analysis of NAD (P): Quinone oxidoreductase 1 in different Iranian ethnic groups. Curr Sci 2006;91:1065-8.
27. Chikako K, Kouichi Y, Koichi T, Yoichi N. NQO1, MPO, and the risk of lung cancer: A HuGE review. Genet Med 2005;7:463-78.
28. Choi JY, Lee KM, Cho SH, Kim SW, Choi HY, Lee SY, et al. CYP2E1 and NQO1 genotypes, smoking and bladder cancer. Pharmacogenetics 2003;13:349-55.
29. Fowke JH, Shu XO, Dai Q, Shintani A, Conaway CC, Chung FL, et al. Urinary isothiocyanate excretion, brassica consumption, and gene polymorphisms among women living in Shanghai, China.Cancer Epidemiol Biomarkers Prev 2003;12:1536-9.